The Kogan.com Ltd [ASX:KGN] share price is up 3.66% to trade at $16.70 at the time of writing. Kogan just announced the acquisition of New Zealand online retailer Mighty Ape. 2020 proved to be a record year for Kogan…
Latest ASX News
The idea of a successful investment portfolio is appealing to everyone.
However, the extremely sensitive and volatile nature of the share market and stocks make it a risky bet.
We see moves in share prices hourly on the ASX. Sometimes, even the most uninformed investors can predict these movements from a mile off.
But often there are complete left-of-field surprises that catch even the most seasoned professionals off-guard.
So, how do you become a responsible investor in the Australian share market? You’ll need more than just your instinct …
Musgrave Minerals’ Share Price Gets Moving on Large, High-Grade Gold
The Musgrave Minerals Ltd [ASX:MGV] share price looks to continue its upwards swing today with the explorer announcing the discovery of large, high-grade gold zones at its Cue Gold Project in WA. We last visited the MGV share price in October, when it was also showing signs of shifting momentum upwards. Though that was clearly […]
Creso Pharma Shares Up 20% as UN Eases Stance on Cannabis
Tiny pot stock Creso Pharma Ltd [ASX:CPH] is soaring today. The CPH share price is trading 22.22% higher at time of writing. A huge boost for investors as the market eyes up this fascinating stock….
4DMedical Ltd Share Price Rises on New Medical Program [ASX:4DX]
4DMedical Ltd [ASX:4DX] rose 7.23% to trade at $2.52 at time of writing. The company announced a new research program with the University of Miami focused on functional lung imaging.
Piedmont Lithium Shares Sink on Feasibility Study (ASX:PLL)
Shares in US-focused lithium developer Piedmont Lithium Ltd (ASX:PLL) have sunk today on the back of the company commencing its definitive feasibility study. At the time of writing the PLL share price is down 5.90% to trade at 36.5 cents per share…
Mesoblast Share Price Up on FDA ‘Fast Track’ Designation (ASX:MSB)
At time of writing the Mesoblast Ltd [ASX:MSB] share price is up 7.26%. Soaring on the back of some exciting news. Their remestemcel-L treatment has secured ‘fast track’ status from the US Food & Drug Administration (FDA)…





